The relevance of EMT in breast cancer metastasis: Correlation or causality?
- PMID: 25979173
- DOI: 10.1016/j.febslet.2015.05.002
The relevance of EMT in breast cancer metastasis: Correlation or causality?
Abstract
Although major progress has been achieved in treating breast cancer patients, metastatic breast cancer still remains a deadly disease. A full understanding of the process of systemic cancer cell dissemination is therefore critical to develop next generation therapies. A plethora of experimental data points toward a central role of an epithelial to mesenchymal transition (EMT) in the multistep cascade of metastasis formation. However, in patients the data are based on correlative studies which often, but not always, tie the expression of EMT markers to cancer invasion, metastasis and poor clinical outcome. Moreover, the notion that cancer cells are able to switch between different modes of migration asks for a thorough review of the actual relevance of EMT in cancer metastasis.
Keywords: Breast cancer; Cell migration; Epithelial to mesenchymal transition; Metastasis; Mouse model.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.Oncol Rep. 2013 Jan;29(1):219-25. doi: 10.3892/or.2012.2111. Epub 2012 Oct 30. Oncol Rep. 2013. PMID: 23129177
-
Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer.Cancer Metastasis Rev. 2012 Dec;31(3-4):469-78. doi: 10.1007/s10555-012-9377-5. Cancer Metastasis Rev. 2012. PMID: 22729277 Review.
-
Epithelial-mesenchymal transition in tumor metastasis.Mol Oncol. 2017 Jan;11(1):28-39. doi: 10.1002/1878-0261.12017. Epub 2016 Dec 9. Mol Oncol. 2017. PMID: 28085222 Free PMC article. Review.
-
Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.Toxicology. 2013 Jan 7;303:139-46. doi: 10.1016/j.tox.2012.09.017. Epub 2012 Nov 9. Toxicology. 2013. PMID: 23146760
-
Breast cancer cells: Focus on the consequences of epithelial-to-mesenchymal transition.Int J Biochem Cell Biol. 2017 Jun;87:23-26. doi: 10.1016/j.biocel.2017.03.014. Epub 2017 Mar 20. Int J Biochem Cell Biol. 2017. PMID: 28336365
Cited by
-
Monascin accelerates anoikis in circulating tumor cells and prevents breast cancer metastasis.Oncol Lett. 2020 Nov;20(5):166. doi: 10.3892/ol.2020.12029. Epub 2020 Aug 27. Oncol Lett. 2020. PMID: 32934733 Free PMC article.
-
E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells.Oncotarget. 2016 Jul 12;7(28):43363-43375. doi: 10.18632/oncotarget.9715. Oncotarget. 2016. PMID: 27270319 Free PMC article.
-
The Rho guanine nucleotide exchange factor ARHGEF5 promotes tumor malignancy via epithelial-mesenchymal transition.Oncogenesis. 2016 Sep 12;5(9):e258. doi: 10.1038/oncsis.2016.59. Oncogenesis. 2016. PMID: 27617642 Free PMC article.
-
Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells.PLoS One. 2018 Sep 4;13(9):e0203397. doi: 10.1371/journal.pone.0203397. eCollection 2018. PLoS One. 2018. PMID: 30180179 Free PMC article.
-
MitoQ Inhibits Human Breast Cancer Cell Migration, Invasion and Clonogenicity.Cancers (Basel). 2022 Mar 16;14(6):1516. doi: 10.3390/cancers14061516. Cancers (Basel). 2022. PMID: 35326667 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
